Recurrence of Papillary Thyroid Cancer Predicted by Genetic Risk Model
Analysis of messenger RNA, microRNA, and protein-encoding genes may predict the risk of papillary thyroid cancer recurrence.
Endocrine Cancer
Apatinib Improves PFS, OS in Radioactive Iodine-Refractory Thyroid Cancer
Apatinib improved progression-free survival regardless of baseline thyroglobulin levels.
Adding Monoclonal Antibody to Induction Could Be New Standard Care for High-Risk Neuroblastoma
Results from a phase 2 trial, if validated in a larger study, may be practice-changing, according to researchers.
¹⁷⁷Lu-Dotatate Provides ‘Clinically Relevant’ Improvement in Midgut Neuroendocrine Tumors
¹⁷⁷Lu-Dotatate improved the median overall survival by 11.7 months.
Regimen May Be Beneficial as Palliative Care for Children, Young Adults With Solid Tumors
Stable disease was observed in 51.3% of patients.
Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden.
Nomogram Could Aid Clinical Decision-Making for Gastroenteropancreatic Neuroendocrine Tumors
The nomogram proved more accurate than TNM staging for predicting 3-year and 5-year overall survival.
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...